Legend Biotech (LEGN) Operating Expenses (2019 - 2025)

Legend Biotech (LEGN) has reported Operating Expenses for 7 consecutive years, with -$138.3 million the latest figure, recorded in Q4 2025.

• Operating Expenses for Q4 2025 came in at -$138.3 million, changed 0.22% year-over-year; the trailing twelve-month figure through Dec 2025 was -$550.5 million (changed 0.03% YoY), and the FY2025 annual result was -$550.5 million, changed 0.04% from the prior year.
• Operating Expenses was -$138.3 million for Q4 2025 at Legend Biotech, up from -$147.9 million in the prior quarter.
• Over five years, Operating Expenses peaked at -$79836.0 in Q1 2021 and troughed at -$172.4 million in Q2 2021.
• Average Operating Expenses over 5 years is -$111.6 million, with a median of -$125.9 million recorded in 2022.
• Year-over-year, Operating Expenses sank 117898.15% in 2022 and surged 99.87% in 2023.
• Over 5 years, Operating Expenses stood at -$103.6 million in 2021, then decreased by 3.66% to -$107.4 million in 2022, then soared by 99.87% to -$134390.0 in 2023, then slumped by 103032.67% to -$138.6 million in 2024, then rose by 0.22% to -$138.3 million in 2025.
• Per Business Quant data, the three most recent Operating Expenses figures were -$138.3 million in Q4 2025, -$147.9 million in Q3 2025, and -$130.9 million in Q2 2025.